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EuroEcho-Imaging 2015 in Seville, Spain: what has
been hot?
The world’s largest cardiovascular imaging conference was held
from 2 to 5 December 2015 in Seville, Spain, at the Sevilla Palacio
de Congresos (FIBES II). It is the annual meeting of the European
Association of Cardiovascular Imaging (EACVI).
Specific teaching courses per modality [echocardiography,
cardiac magnetic resonance (CMR), and nuclear/computed tomog-
raphy (CT)] were dedicated to enrich the multi-modality nature
of the congress. Moreover, cutting edge research has been pre-
sented on 3D printing in valve disease, robotic echocardiography,
and fusion imaging. New methods in molecular imaging have been
presented that use all the imaging modalities to detect subtle patho-
physiological processes.
The 2015 themes were ‘cardiomyopathies’ and ‘early diagnosis of
cardiovascular diseases’.
The theme on cardiomyopathy encompasses a number of topics,
including the intensely debated role of imaging in selecting patients
for cardiac resynchronisation therapy, new ways to assess cardiac
remodelling, ischaemic heart disease in women, how to treat heart
failure with preserved ejection fraction and whether emerging car-
diac imaging technologies are now sensitive enough to detect early
signals of cardiovascular risk.
Approximately 3200 delegates from .90 countries attended, in-
cluding cardiologists, cardiac ultrasonographers, anaesthesiologists,
nuclear physicians, paediatric cardiologists, surgeons, scientific engi-
neers, nurses, general practitioners, and medical technicians.
During 3.5 days of congress, there were 156 scientific sessions
and nearly 900 abstracts presented from almost 1260 submissions.
The terrible events that had occurred around the world did not dis-
courage the 356 faculty members to keep education on-going.
The role of computer modelling in
congenital heart disease
Patients with congenital heart disease may have complex haemo-
dynamic circuits. Computer modelling derived from a mathematical
concept could help improve our understanding of how changes in
haemodynamic variables influence the circulation.
For example, in Fontan patients, it has been shown that an in-
crease in central venous pressure during exercise is necessary for
adequate pulmonary flow, but the same increase limits the reserve
capacity for cardiac output. Computer modelling can go one step
further and help with surgical decision-making by simulating differ-
ent surgical interventions (Figure 1).
Geometric and haemodynamic variables are adapted at once, and
the effect on the circulation is evaluated immediately. However,
computer modelling does not predict the clinical outcome, does
not account for all biological processes, does not dictate clinical de-
cisions, and cannot replace the bedside assessment.
Computer modelling might also serve as a platform for innovation
and can test haemodynamic models that no one would attempt in
humans. The validation of this computer-based concept can be
done in silico or in vitro, and might reduce the number of animal tests.
However, computer modelling simulates not only haemodynamic
data but can also be applied to study the myocardium itself, or to
unravel the electro-mechanical activation of the heart. The latter
has progressed quite far in patients after Tetralogy of Fallot repair
and might open avenues towards a better understanding of the final
result of interventions.
Computer modelling is evolving rapidly, and will presumably be a
part of our daily practice in the future. However, models need to be
developed with accurate and continuously updated datasets. Valid-
ation in clinical practice by close cooperation between engineers,
computer scientists, and clinicians is mandatory.
Sport: friend or foe? Lessons from
imaging
In this session, the speakers were asked to consider whether exer-
cise training could serve as a support to physical therapy and to de-
scribe the main aspects of the athlete’s heart.
In the first presentation, the speaker focused on the possibility of
monitoring the beneficial effects of cardiac rehabilitation therapy by
non-invasive imaging. Exercise prescription commonly refers to a
specific plan of fitness-related activities that are designed for a spe-
cified purpose, which is developed by a fitness or rehabilitation spe-
cialist for the individual patient.
An exercise prescription should generally include the follow-
ing recommendations: (i) type of exercise or activity (endurance/
training), (ii) specific workloads, (iii) duration and frequency of the
activity or exercise session, and (iv) intensity guidelines including tar-
get heart rate range and estimated rate of perceived exertion.
Using both clinical evaluation and imaging techniques, the cardi-
ologist should perform the initial assessment, management, and sta-
bilization of the patient. Exercise stress test has then a pivotal role in
the evaluation of functional capacity and a regular clinical follow-up
is necessary for the reassessment of symptoms, exercise progress,
and cardiac remodelling.
During regular clinical follow-up for exercise progress and symp-
toms reassessment, the cardiologist should evaluate the progress of
exercise tolerance, evaluate cardiac remodelling and ischaemic
burden and if necessary, modify the prescription according to the
improvement in fitness.
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The second presentation focused on the chronic adaptations typ-
ical of the athlete’s heart. A multi-modality imaging approach to the
athlete’s heart aims to differentiate physiological changes due to in-
tensive training from serious cardiac diseases with similar morpho-
logical features. Imaging assessment of the athlete should begin with
a thorough echocardiographic examination.
The measure of left ventricular (LV) wall thickness by echocardi-
ography can contribute to the distinction between athlete’s LV
hypertrophy and hypertrophic cardiomyopathy (HCM). In patients
with HCM, the LV end-diastolic diameter exceeds normal limits only
at the end stage of the disease, when the LV ejection fraction is
≤50%. Patients with HCM also show early impairment of LV diastol-
ic function, whereas athletes have normal diastolic function.
When echocardiography cannot provide a clear differential diag-
nosis, CMR should be performed. Cardiac magnetic resonance al-
lows an accurate morphological and functional assessment of the
heart. Tissue characterization by late gadolinium enhancement
may show a distinctive, non-ischaemic pattern in HCM, which can
help in differentiating this pathology from other myocardial diseases,
such as idiopathic dilated cardiomyopathy or myocarditis.
In the final presentation, the speaker underlined the effects of ex-
treme sports on right ventricular (RV) function. While strength
training seems to impact minimally on the right ventricle, endurance
exercise is associated with the most extensive cardiac remodelling.
Previous reports have described a disproportionate load on RV dur-
ing exercise. Although the reversibility of the ventricular changes in-
duced by sport after detraining is considered a typical feature of
athlete’s heart, several studies have shown that recovery might be
incomplete, in particular for RV changes and this is particularly
true in more highly trained athletes.
In conclusion, the type, intensity, and the duration of sports
training should be strongly considered together with other factors
(age, male sex, black ethnicity, and body surface area) as the main
determinants of cardiovascular adaptations to physical exercise.
3D in assessing cardiac chambers
The session started with a talk from Dr Karina Addetia from Chicago
who covered why we need 3D for assessing the LV. She explained the
limitations of conventional methods of LV evaluation, from the ‘eye-
ball’ technique right through to Simpson’s bi-plane, which is suscep-
tible to foreshortening and the lack of accuracy in distorted
ventricles. Dr Addetia explained very clearly why the current EACVI
and ASE guidelines recommend the use of 3D where it is feasible and
where the necessary expertise exists. She also demonstrated why 3D
could give us new information on LV shape and apical curvature, both
of which appear to be prognostically important.
We moved across to the RV with the next presentation from
Dr Nozami Watanabe from Japan. The RV has a complex shape
and it is very easy to undersize it with 2D Echo. She explained how
dedicated 3D analysis software could help overcome this.
In addition, evaluation of the tricuspid valve annulus appears import-
ant and can be achieved using 3D techniques. The take home message
was that 3D RV assessment, while being more accurate than 2D,
should be used in combination with other parameters of RV function.
The last presentation in this session addressed the remaining two
cardiac chambers and Prof Victor Mor-Avi elegantly covered the
role of 3D Echo in assessing the left and right atria. He started by
explaining why measurement of LA size is so important for progno-
sis, predicting cardiac events and assessing diastolic function. It was
clear from the data presented by Prof Mor-Avi that 3D LA volumes
are so much better than linear dimensions or LA areas in predicting
outcomes. He then went on to explain that the conventional meth-
ods of measuring LA volumes (area—length and Simpson’s bi-plane)
are very limited and potentially inaccurate.
Three-dimensioanal Echo assessment of volumes correlate much
better with CMR than the older, more traditional methods and have
led to a change in normal values contained in the Guidelines. Three-
dimensioanal also gives us the possibility of looking at the dynamic
function of the LA and also measuring 3D LA strain. The latter par-
ameter is proving very useful in terms of predicting the development
of AF in selected patient groups. Prof Mor-Avi concluded his talk
by explaining that the same principles apply to the right atrium,
although less data currently exists.
Cardiovascular magnetic
resonance for valvular heart
disease
Echocardiography is the mainstay imaging technique to evaluate pa-
tients with valvular heart disease. The complementary role of CMR
in the evaluation of valvular heart disease was underscored in this
session. In patients with challenging acoustic windows and inconsist-
ently graded severity of valvular heart disease, CMR provides
high spatial resolution data to characterize the valve anatomy
(i.e. to differentiate between bicuspid and tricuspid aortic valve),
quantify cardiac chamber dimensions and function and to assess
the dimensions of the aorta. In terms of evaluating valve haemo-
dynamics, CMR has been shown accurate to quantify the severity
of valvular dysfunction, although it has a lower temporal resolution
compared with echocardiography.
Dr Le Ven presented interesting data on the assessment of the
anatomy and effective orifice area quantification in stenotic and re-
gurgitant valve lesions. In addition, Dr Le Ven underscored the
growing interest in the effects of the valvular lesion on left ventricu-
lar mechanics, beyond the simple measurement of LV ejection frac-
tion. With the use of late gadolinium enhancement, replacement
and diffuse myocardial fibrosis can be assessed with CMR.
The presence of replacement fibrosis has been associated with
prognosis and clinical outcomes after surgical treatment of valve
Figure 1 Example of 3D printing model in a case of complex
double outlet ventricle allowing the surgeon to plan the interven-




by Bibliotheque Fac de Medecine user
on 25 January 2018
disease (i.e. symptom relief, LV functional recovery). However, the
clinical implications of the assessment of diffuse fibrosis remain un-
der investigation and further studies are needed. Advances in post-
processing software and standardization of data acquisition will help
to implement this technique in clinical practice.
Dr Kilner provided new insights into the pathophysiology
of mitral valve prolapse, highlighting specific phenotypes of the
left ventricle and mitral annulus dynamics that can be assessed
with cine CMR.
Dr Alpendurada provided a comprehensive overview of the
role of CMR to evaluate patients with bicuspid aortic valves, with
particular focus on associated aortopathy and life-threatening com-
plications such as aortic dissection.
Finally, as a glimpse into the near future, Dr. Ebbers summarized
the technical aspects of 4D flow assessment with CMR. 4D flow as-
sessment is the most frequently used method to visualize (stream-
lines, path-lines and vectors) and to quantify (peak velocities and
flow volume) blood flow through the valves. Whether this imaging
application is ready for use in clinical practice, and whether it has
consequences for the management of patients with valvular heart
disease remains to be demonstrated.
News from EuroEcho-Imaging 2015
Foetal heart changes
Changes in foetal hearts found in pregnant women with diabetes or
obesity need more studies to find out if foetal changes affect cardio-
vascular health.
Changes in foetal hearts have been
found in pregnant women with diabetes
or obesity, in research presented at Euro-
Echo-Imaging 2015 by Dr Aparna Kulkarni,
paediatric cardiologist from the Bronx,
New York, USA.
In the USA, pregnant women with
diabetes and some with obesity are routinely referred for standard
of care foetal echocardiograms. During 2012–2015, the study pro-
spectively enrolled 82 pregnant women with diabetes and 26 preg-
nant obese women with a body mass index of.30 kg/m2. A control
group of 70 healthy pregnant women who volunteered to have a
foetal echocardiogram was used for comparison.
The researchers examined the echocardiograms to see how
well the heart muscle of each foetus was contracting and relaxing.
Next they processed the pictures using speckle tracking to generate
more detailed information on heart muscle function by evaluating
the heart muscle motion.
The researchers found subclinical changes in the myocardium of
foetuses of mothers with diabetes and also foetuses of mothers
with obesity, compared with the foetuses of healthy women. The
changes were not apparent by routine echocardiographic techniques.
Dr Kulkarni said further studies were needed to find out if these
foetal changes affect cardiovascular health as a child or an adult,
when during pregnancy the hearts are affected and whether anything
can be done to alter this course. As an extension of the current study,
Dr Kulkarni will examine the babies’ hearts at 1 year of age to see if
the abnormalities are still present, get worse, or have disappeared.
Dr Kulkarni concluded: ‘I don’t want pregnant women with diabetes
or obesity to think that something will definitely go wrong with their
pregnancy. We need more answers about what impact diabetes and
obesity in the mother may have on the child after birth, before coming
to firm conclusions about implications for the health of the baby.’
Can cancer itself damage
the heart?
Research presented at EuroEcho-Imaging 2015 raises the possibility
that cancer itself may damage heart muscle irrespective of exposure
to cancer drug therapies. Researchers from the UK’s first dedicated
cardio-oncology clinic found that both treated and untreated cancer
patients had impaired heart function.
‘It is well known that chemotherapy is
potentially toxic to the heart, making cancer pa-
tients more prone to cardiovascular complica-
tions,’ said Dr Rajdeep S. Khattar, consultant
cardiologist at the Royal Brompton Hospital
in London, UK. ‘Our study raises the possibility
that tumour growth itself may also damage the
heart which could have important implications for monitoring.’
Previous studies have shown that cancer patients who have had
chemotherapy can have a normal ejection fraction but reduced strain
and that this may predict subsequent cardiotoxicity. The current study
carried this finding a step further to see if untreated cancer patients
with a normal ejection fraction also had reduced strain measurements.
The study compared myocardial strain in three groups with a nor-
mal ejection fraction (55% or more): 43 patients with cancer who
were currently being treated or had received treatment in the
past, 36 patients with as yet untreated cancer, and 20 healthy indi-
viduals matched to the cancer groups for age and gender.
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The researchers found that both groups of cancer patients had simi-
larly reduced strain measurements compared to the healthy individuals.
Dr Khattar said: ‘What was really new was the finding of reduced
strain, and therefore myocardial dysfunction, in the group of patients
with cancer who had not yet received treatment. This raises the
possibility that the tumour itself may have a direct and deleterious
effect on the function of the heart.’
Patients with reduced strain before they start their cancer drug
therapies may be predisposed to developing heart failure during
the course of their treatment and need closer monitoring.
Chagas disease in Spain
Latin American migrants in Spain should be screened for Chagas dis-
ease, particularly women before pregnancy, doctors urged at
EuroEcho-Imaging 2015.
Chagas disease is caused by the protozoan Trypanosoma cruzi.
It is endemic in Latin America, where it is transmitted by bloodsucking
insects that typically live in the cracks of poorly constructed homes.
Up to 40% of patients develop a chronic disease that primarily affects
the heart and bowel and carries a high risk of sudden cardiac death.
Around 4.2% of the Latin American community living in Europe
is infected with Chagas disease. Spain is the most highly affected
country in Europe with between 50 000 and 70 000 patients.
Mother-to-child is most common transmission route in Spain.
The study included 145 patients with the parasite. Patients were
43 years old on average, 68% were women and 93% were from Bo-
livia. More than one-third (34%) had an abnormal electrocardio-
gram, and of those, 31% had bradycardia. The most common
heart block was right bundle branch block.
More than 38% of patients had an abnormal
trans-thoracic echocardiogram. Of these, 34%
had a dilated left atrium and almost 15% had dia-
stolic dysfunction. ‘Almost none of these patients
had hypertension,’ said author Dr Carlos
A. A´lvarez-Ortega. ‘It suggests that the abnormal-
ities are the result of Chagas heart disease in these
young, asymptomatic patients.’
According to the modified Rassi scale, which predicts Chagas
patients’ risk of dying in the next 4 years, 94% patients in the study
were at low risk, 4% were at intermediate, risk and 2% were at high risk.
The European Association of Cardiovascular
Imaging
The cardiovascular sciences, particularly non-invasive imaging meth-
ods, have been among the leading techniques in the constant ad-
vances in health technologies during the last two decades.
As a result, in recent years, new and reliable methods of non-invasive
imaging have emerged in the cardiovascular arena. Although until recent-
ly cardiovascular imaging tests were based primarily on conventional nu-
clear and ultrasound methods, today the scenario is completely different.
New non-invasive methods such as computerized tomography
(CT), cardiac magnetic resonance (CMR), and cardiac positron
emission tomography have definitely entered into the clinical set-
ting. These powerful new methods are useful, not only in the iden-
tification of preclinical disease and of its progression but also in the
clinical assessment of cardiovascular diseases (acute or chronic),
whether in terms of diagnosis or evaluation of the effectiveness of
different treatment modalities or in describing prognosis.
The European Association of Cardiovascular Imaging (EACVI)
created in 2003 (from the fusion of the former European
Association of Echocardiography, Working Group on Nuclear Car-
diology & Cardiac Computed Tomography, and Working Group on
Cardiovascular Magnetic Resonance), a registered branch of the
European Society of Cardiology (ESC), is the leading international
network in multimodality cardiac imaging.
The EACVI is a united group of experts and knowledge providers
in echocardiography, nuclear cardiology, cardiac computed tomog-
raphy, and cardiovascular magnetic resonance, whose mission is ‘to
promote excellence in clinical diagnosis, research, technical devel-
opment and education in cardiovascular imaging in Europe’. The
EACVI assets are, besides its huge imaging expertise, key opinion
leaders in clinical cardiology which enable a simple and rapid integra-
tion of clinical and imaging data, leading to an early correct diagnosis
and treatment plan (medical treatment, devices, surgery).
The creation of the EACVI represents new, exciting, enthusiastic,
and historical times—with a new constitution, a new mission, and a
new structure—but also introduces new challenges to the cardiac
imaging community. It involves a close interaction and scientific
communication between specialists of different imaging techniques
that now work together in an integrated and rational way with an
‘esprit de corps’ and team-building approach, yet on the other
hand, keeping alive the individuality of each imaging technique.
This collaboration of the modalities not only reflects the importance
of moving from a technology-based approach to a patient-based ap-
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Although advantages exist in the different imaging methods, there
are also some new problems, as in some cases the information pro-
vided by different methods overlap.
It is therefore necessary to create new diagnostic algorithms that in-
clude these new technologies, incorporating them in a logical se-
quence in the diagnostic work-up of a specific disease, allowing the
rational use of the different methods and defining the timing and selec-
tion of the imaging technique indicated in each specific clinical setting.
The selection of test used in each case must therefore lay in the
thorough knowledge of what each method can provide and in the
advantages and disadvantages of each one compared with another,
in terms of information, diagnostic ability, reliability, safety, and im-
pact in clinical outcomes.
To achieve these aims, the collaboration between different im-
aging subspecialties should be encouraged, specifically with guide-
lines and joint protocols. The concept that the different methods
are complementary and not competitive is very important. In this
context of multidisciplinary interaction and complementing, it is
therefore recommended that an expert in a particular imaging tech-
nique has some theoretical knowledge and practical experience in
all imaging modalities.
The Association has three Sections (echocardiography section,
cardiovascular magnetic resonance section, nuclear cardiology,
and cardiac CT section) which work closely together on all aspects
of cardiovascular imaging with a particular focus on education, train-
ing, and scientific initiatives.
The echocardiography section major objectives include the dis-
semination of education and recommendations to echocardiog-
raphy practitioners and cardiologists, not only in Europe but also
worldwide.
The cardiovascular magnetic resonance section aims at being the
representative trans-national scientific organization for physicians,
scientists, and technologists who work in the field of CMR. The pur-
poses of the EACVI CMR section are to stimulate and disseminate
knowledge and the use of CMR through education, quality control,
research, and training.
The Nuclear Cardiology and Cardiac CT section is dedicated to
promoting education, research, and clinical excellence in the fields
of Nuclear Cardiology and Cardiac CT, as well as collaboration be-
tween all cardiovascular imaging modalities.
With 12 different committees, each one integrating members of
the three different imaging sections [club 35/HIT (heart imagers of
tomorrow) committee, European communities committee, Indus-
try round table committee, Scientific documents committee, Re-
search & innovation committee, Education committee, Web &
communication committee, International affairs committee, Certifi-
cation & accreditation, Euroecho-imaging scientific programme
committee, EuroCMR 2016 scientific programme committee, and
ICNC 2017 scientific programme committee] and.5000 members
(we are proud to be the largest ESC Association!), the EACVI is
committed to maintaining the highest standards of professional ex-
cellence in all aspects of cardiovascular imaging.
The EACVI journal, the European Heart Journal of Cardiovascular
Imaging, is now a high scientific quality and high impact factor journal,
contributing to the EACVI mission, providing excellence in clinical
research in all field of cardiovascular imaging.
Our major aims for the near future include, among others, the fol-
lowing ideas and concepts:
(1) Think of imaging rather than on Echo, CMR, nuclear imaging,
or CT.
(2) Develop a strong international network (Europe + other
countries).
(3) Create new strategies to increase membership.
(4) Move towards common procedures for different imaging tech-
niques (for instance, certification & accreditation).
(5) Education- web: develop multimodality imaging packages/
algorithms by pathology/clinical problems.
(6) Research: increase transversal projects (EURObservational
Research Programme, other ESC associations, and Working
Groups).
(7) EHJ-CVI-strong support for the Editors to create strategies to
improve the overall quality/impact factor.
We have created a new and large Association!
It is now time to stay together, work together, and grow together,
working hard with good friends in a nice atmosphere, to the highest
scientific level.
The Annual Congress of the Spanish Society
of Cardiology
The Sociedad Espan˜ola de Cardiologia was held 22–24 October,
2015, in Bilbao, Spain
As every year the Spanish Society of Cardiology (SEC) met with all
its members and interested physicians in Bilbao in the Basque Coun-
try at the end of October 2015 (Figure 1).
Overall, the congress which was organized this year by Prof. Lina
Badimon, FESC, Vice-president of SEC and Director of the Cardio-
vascular Research Center (CSIC-ICCC, Hospital de Sant Pau) in
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Barcelona, an internationally known cardiovascular scientist with a
focus on vascular disease and thrombosis, attracted3500 participants.
Lina Badimon was trained for 2 years in the
USA at the Mayo Clinic and worked as Director
of Cardiology Research at Mount Sinai Medical
Center and the Massachusetts General Hospital-
Harvard University for 12 additional years be-
fore returning to Spain her home country.
Lina Badimon with the help of the Scientific
Committee of SEC-2015 focussed the programme of this years’ An-
nual Congress of the SEC on a well-balanced merge of the different
subspecialty areas within cardiology with a special input on research
coming from hospitals and research centres in the country. This
year the abstract submission reached a record number, when
.1500 abstracts were received.
The opening ceremony featured welcome addresses from nation-
al politicians, from Prof. Lina Badimon as Vice-president and Prof.
Jose-Ramon Gonzalez-Juanatey as President of SEC, from Prof.
Fausto Pinto as President of ESC, from Dr Richard Chazal as Vice-
president of ACC and Dr Gregg Fonarow on behalf of AHA.
An excellent Opening Lecture entitled ‘From Eisenhower’s Heart
Attack to Modern Cardiology’ was delivered by Prof. Thomas
F. Lu¨scher, editor-in-chief of the European Heart Journal and Profes-
sor and Chairman of Cardiology at the University of Zurich
(Figure 2).
During the ceremony, the SEC awards were also given to this
year’s awardees. A record number of 18 research grants (7 for basic
science, 4 in translational science and 7 in clinical science) and 7
post-residency mobility Fellowships were awarded.
As every year the Portuguese Society of Cardiology and several
societies from South America were represented in our congress.
Sociedad Interamericana de Cardiologı´a, Sociedad Mejicana de
Cardiologı´a and Sociedad Venezolana de Cardiologı´a joined in
Bilbao.
During the 4 years of Prof. Badimon’s contribution to the annual
scientific congress of the SEC a strategic policy was implemented to
increase the presence of innovation and fundamental scientific re-
search at the congress. As such in Bilbao, ‘Cardioscience’, ‘Advance-
ments in Science’, and ‘Science in Practice’ sessions focusing on the
different levels of progression of novelties in cardiology, from basic
Figure 1 SEC 2015.
Figure 2 Thomas F. Lu¨scher, Eisenhower Lecture.
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science to translational science to initial clinical application were
successfully held.
The ‘Hot Topics in Cardiology’ focused on the scientific basis of
cardiovascular disease and its implications for the management of
cardiac conditions. A total of 36 internationally known experts
gave lectures in our congress.
Also this year, as a novelty, we had two Joint Sessions of SEC with
two ESC-scientific bodies. The ESC-Working Group on Coronary
Pathophysiology and the Microcirculation, and the Council of
Hypertension, had highly successful sessions that elicited construct-
ive discussions.
The educational part of the programme is also very important be-
cause the congress has the objective of fostering the young commu-
nities of residents and cardiology research Fellows. This educational
section is composed of different session formats but the Clinical
Cases, Electros, and Imaging Competitions are lively and highly
appreciated.
Furthermore, a shared meeting of the Revista Espan˜ola de Cardio-
logia and the European Heart Journal was held on Friday, 23 October,
2015 with Juan Sanchis and Thomas F. Lu¨scher as chairpersons. The
most interesting papers of the Revista Espan˜ola de Cardiologia were
presented and discussed by experts from SEC. Furthermore, a cur-
rent opinion paper published in the European Heart Journal on quality
assessments in cardiovascular care rounded up this interesting
session.
Overall, this year’s Annual Meeting of the SEC was indeed a suc-
cess both from the number of attendees and the quality of the
meeting.
Lina Badimon
Vice-president Spanish Society of Cardiology,
Director, Cardiovascular Research Center,
Hospital de Sant Pau, Barcelona
lbadimon@csic-iccc.org
European Society of Cardiology Chief
Executive Officer wins Professional
Convention Management Association
Chairman’s Award
Isabel Bardinet European Society of Cardiology Chief Executive
Officer received the 2015 Professional Convention Management
Association (PCMA) Chairman’s Award in January, presented at
the PCMA Convening Leaders conference in Vancouver, Canada
The award is the highest honour bestowed by the Chairman of the
Professional Convention Management Association (PCMA).
Isabel Bardinet was acknowledged for her creative involvement
of the community in advancing the European Society of Cardi-
ology (ESC)’s mission at ESC Congress 2015. European Society
of Cardiology staff teamed up with local partners to create the
London Heart Trail, an interactive walk along London’s iconic
South Bank with a specific aim of promoting awareness of heart
health to the London public.
European Society of Cardiology Congress, the ESC’s annual
event, is the world’s largest and most influential cardiovascular
meeting. In 2015, the 5-day conference attracted 34 000 delegates
to ExCeL London. Isabel Bardinet said: ‘Recognition from PCMA,
who is a standard setter for our profession, means an awful lot to us.’
The ESC’s mission is to reduce the burden of cardiovascular disease
in Europe. This burden affects nearly one person in four worldwide
and kills over four million people in Europe alone every year. Educa-
tion, sharing and dissemination are our main tools to deal with this
pandemic. The most visible of our activities is ESC Congress.
The Heart Trail was organised and implemented for the people in
London during the congress to get the messages of prevention across
to them and indirectly thereby save lives. The success of the Heart
Trail was mostly thanks to London & Partners and ExCeL, without
whom this would never have been possible.
On behalf of the London Team – that is to say London & Partners,
ExCeL, ESC staff and volunteers – I would like to thank PCMA for
such a wonderful reward which means so much to us all.
James Rees, Executive Director at ExCeL London, said: ‘On be-
half of ExCeL London, I would like to congratulate Isabel Bardi-
net on winning the PCMA Chairman’s Award. This is
hugely-deserved recognition and we are thrilled for her and
the ESC team. Isabel is a thought-leader in our industry who re-
cognises, and champions, the role of events to support the mis-
sions of medical associations and leave a legacy of positive
change in the destinations they select. It was a pleasure for us
to work with ESC and London as a whole during 2015 to host
the ESC Congress and raise awareness of the healthy changes
that can be made to reduce the burden of cardiovascular disease
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People’s corner: new appointment
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Holger Thiele MD
Holger Thiele, former deputy director of
the department of internal medicine/cardi-
ology at the Heart Center of the University
Leipzig, Germany, has been appointed full
Professor and Director of the Medical Clinic
II (Cardiology/Angiology and Intensive
Care medicine) of the University Hospital
Schleswig-Holstein, Campus Lu¨beck, Germany, by the faculty of
the University of Lu¨beck.
Holger Thiele studied medicine in Berlin and obtained his clin-
ical training at the Heart Center of the University of Leipzig under
the leadership of Professor Gerhard Schuler. During his training,
he worked as a Research Fellow in the field of cardiac magnetic
resonance imaging at the German Heart Institute in Berlin and
also at the Leeds General Infirmary, University of Leeds, UK.
Holger Thiele has a major research interest in the treatment of
acute coronary syndromes including all complications particularly
cardiogenic shock. Furthermore, he implemented cardiac mag-
netic resonance imaging as a tool for prognosis estimation in pa-
tients with acute coronary syndromes. He provided major
contributions to the treatment of acute coronary syndromes by
performing large multicentre trials evaluating the best adjunctive
therapy for reperfusion.
In cardiogenic shock, he was the principal investigator of the
IABP-SHOCK II trial which led to the downgrading of the
intra-aortic balloon pump from a former Class I recommendation
to a Class III recommendation in recent guidelines. He contribu-
ted further to the understanding of the pathophysiology and
prognosis of cardiogenic shock by other multiple trials in cardio-
genic shock. Currently, Holger Thiele is performing other
large-scale randomized multicentre trials evaluating the optimal
reperfusion strategy in patients with cardiogenic shock complicat-
ing acute myocardial infarction who have multivessel disease. This
EU-funded trial will also allow further understanding of the prog-
nosis and the pathophysiology of cardiogenic shock.
Similarly, his work on cardiovascular magnetic resonance in
the differential diagnosis of acute coronary syndromes including
myocarditis, Takotsubo-cardiomyopathy, and other infiltrative
and inflammatory diseases has significantly contributed to
the better understanding of the conditions. Large Takotsubo-
cardiomyopathy registries were well suited to understanding
this not so rare disease.
He states that Lu¨beck is now the ideal landing zone for him to
pursue this effort with major clinical trials because of its great
tradition as a hub for innovation and because of the possibilities
Lu¨beck offers as a partner site of the German Center for Cardio-
vascular Research.
Apart from work where he endeavours to be a good teacher,
chief, and also a good physician, his family, friends, soccer, long-
distance running as well cycling are of major importance.
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